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location of mJSW) there is a steep change in the JSN proﬁle for KL3 sub-
jects and a crossing of the Non OA and KL2 plots. The Std Dev of the
measurements, are relatively consistent from 50 to 100%.
mJSW narrowing aJSN 51−90%
Mean Std Dev SRM p Mean Std Dev SRM p
KL0 −0.07 0.31 −0.235 0.20 −0.12 0.25 −0.478 0.01
KL2 −0.14 0.42 −0.336 0.19 −0.04 0.34 −0.124 0.62
KL3 −0.43 0.63 −0.687 0.008 −0.45 0.56 −0.795 0.003
Conclusions: This study is unique in that it measured the JSN proﬁle
from Lyon schuss X-rays. The range of 51%-90% for the aJSN measure-
ments was chosen because it was an area of fairly consistent narrowing
as well as low Std Dev for the measurements. For KL3, both mJSN and
aJSN 51−90% showed signiﬁcant change but the latter had a higher
SRM and hence is potentially more sensitive. While the Non-OA had a
signiﬁcant and unexpected change in aJSN 51−90% it should be noted
that direct comparisons between the two methods were not signiﬁcantly
different. The aJSN measures may provide additional information regard-
ing OA progression in the medial compartment to mJSW narrowing alone
and further investigation is warranted to determine how these measures
reﬂect the complicated underlying biological progression of OA.
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Purpose: Biomechanical behaviour of articular cartilage in-vivo is hardly
to assess. However, taking into consideration that walking and standing
is loading, hence deformation of collagen structure and water content
changes after rest. T2 mapping is an adequate approach for the evalu-
ation of collagen structure and water content. The goal was to use T2
mapping and its zonal assessment for evaluation of unloading during a
one hour MR scan in healthy volunteers, patients with cartilage defect
and in the follow-up after cartilage repair (MACT).
Methods: 3T MRI was performed using a multi-echo spin-echo (SE) in 10
volunteers and Twenty-ﬁve patients: Eight patients pre-operatively with a
single partial thickness cartilage defect on the femoral condyle and 17 pa-
tients 20.7±16.9 months after MACT. T2 relaxation times were obtained
using a pixel wise, mono-exponential (NNLS) ﬁt analysis. T2 sequence
was obtained at the beginning (pre-scan) and at the end (post-scan)
of the clinical MR examination, including high resolution morphological
scan. The time gap between both T2 measurements was 45 minutes. The
patients were asked to not rest before the MR scan, so daily activity and
walking to the scanner was used as loading. were enrolled in this study.
within the knee. Regions of interest (ROI) analysis were manually done
in consensus and areas of cartilage damage/cartilage repair and healthy
control cartilage were identiﬁed using the morphological images as well
as surgical reports. All areas were located within the weight bearing zone
of the femoral cartilage. For further evaluation on the zonal variation, the
ROIs were divided into two equal sized deep and superﬁcial regions.
Results: For healthy seen cartilage quantitative T2 values for the
pre-unloading evaluation were 50.9±13.1ms for the deep zone and
56.0±10.9ms for the superﬁcial zone. After 45 minutes T2 values showed
not signiﬁcant increase to 51.2±13.3ms for the deep aspects and
57.7±12.8ms for the superﬁcial aspect. The increase between deep
and superﬁcial T2 values was signiﬁcant. Pre-operative patients show
initial signiﬁcant lower T2 values with 41.5±6.0ms for the deep zone
and 50.4±6.4ms for the superﬁcial zone, however after unloading, val-
ues rise signiﬁcantly to 52.6±14.3 for the deep and 58.5±14.3 for the
superﬁcial aspect. The cartilage repair tissue after MACT showed pre
values of 51.9±11.6ms for the deep cartilage zone and 55.9±14.1 for the
superﬁcial (Pre and Post T2 and Substraction Image shown in Figure 1).
Thus there was no signiﬁcant difference from the healthy seen cartilage
sites, the post-unloading scan showed a signiﬁcant increase in T2 values
for deep (56.3±14.1ms) and even clearer for superﬁcial (60.8±18.5ms)
aspects of cartilage repair tissue.
Conclusions: Quantitative T2 relaxation can be used to assess pre- and
post unloading values of articular cartilage in a clinical setup. Furthermore
the presented approach of two SE-T2 scans at the beginning and the
end of an MR scan might give additional information on the constitution
of cartilage and might help to differentiate between healthy and affected
articular cartilage. However it appears that changes in water content and
anisotropy over time are different in healthy cartilage compared to altered
cartilage. Larger patient groups have to elucidate a potential clinical
impact of the presented approach.
Figure 1. Quantitative T2 Map of a patient after MACT: Top left image
shows the pre-unloading scan, top right image the post-unloading scan.
The image at bottom shows the substracted T2 map (post − pre value),
with changed repair tissue.
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Purpose: The objective of this pilot study was to explore the structure
modifying effect of Structum® (Chondroitin Sulfate) in knee osteoarthritis
(KOA) using quantitative and qualitative magnetic resonance imaging
(MRI).
Methods: Multicenter, double-blind, placebo-controlled, parallel-group
study. Forty-three patients over 50 years with KOA (ACR criteria),
graded II or III on Kellgren-Lawrence scale, were randomized to re-
ceive either Structum® 500mg (N=22) or placebo (N=21) twice daily
for 48 weeks. Clinical symptomatology was assessed throughout the
Lequesne index and VAS for pain during daily activities, at baseline 24
and 48 weeks. In parallel 3D MRI imaging was acquired at baseline, 24
and 48 weeks. Global and compartments cartilage volume was quantiﬁed
as well as other MRI features such as joint cartilage abnormalities,
meniscal lesions, ligaments abnormalities, synovitis, synovial effusion,
osteophytes, subchondral cysts, popliteal cysts and subchondral oedema.
Intra- and inter-reproducibility of MRI was tested by the Spearman cor-
relation coefﬁcient for quantitative assessments and by the kappa coef-
ﬁcient for qualitative assessments. Treatment groups were compared by
an analysis of covariance (ANCOVA) with baseline value as a covariate.
Results: Demographic data for the Structum® and placebo groups were
as follow: mean (SD) age 63.6 (8.2) and 66.5 (8.1) respectively, female
sex 72.7% and 57.1%. At baseline clinical signs and total volume of
cartilage were comparable in both groups: Mean Lequesne index was
9.6 (3.4) in the Structum® group and 10.4 (3.6) in the placebo, pain
VAS 50.9 (15.9) and 55.4 (14.5) and mean total cartilage volume was
12969.8mm3 (3657.7) and 13916.9mm3 (4439.2). At baseline we ob-
served a highly signiﬁcant correlation for the assessment of cartilage
volumes, number of cysts and osteophytes, the Spearman coefﬁcients
ranging from 0.951 to 0.980 for the within investigator and from 0.714 to
0.957 for the between investigator. Between investigator reproducibility
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was slightly lower, but still acceptable, for the assessment of synovial
effusion, cartilage abnormalities, ligaments abnormalities and meniscus
ﬁssure grade. A correlation was observed between pain VAS score at
baseline and the subchondral oedema (r = 0.24).
After 48 weeks, an improvement of symptomatology was observed in
both treatment groups without signiﬁcant difference between groups.
An increase in total cartilage volume was observed in the Structum®
group (+180mm3 +SD) whereas a loss was revealed in the placebo
(−46mm3 +SD). However, due to the very high variability of measure-
ments, no signiﬁcant treatment effect could be shown.
No statitistically signiﬁcant differences between groups were observed
for subchondral oedema, osteophytes, subchondral cysts, meniscus ﬁs-
sure grade, cartilage abnormalities, synovitis or synovial effusion. No
correlations were evidenced between key MRI parameters changes after
48 weeks and clinical symptomatology.
Conclusions: Despite the weak correlation between clinical symptoms
and MRI, the observed difference in the evolution of cartilage volume be-
tween the 2 groups could reﬂect a structure modifying effect of Structum®.
Hence, a larger and longer longitudinal study will be needed to conﬁrm
MRI ﬁndings.
This pilot study conﬁrm the usefulness of quantitative and qualitative MRI
as a sensitive tool to assess a structure modifying drugs in KOA.
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Purpose: The major risk factors for osteoarthritis (OA) are known, allow-
ing to identify high-risk groups. Several biochemical markers and imaging
techniques are available that may identify early signs of OA. Because of
the chronic progressive character of OA and severe disability and pain
to which it can lead, early treatment in a pre-clinical stage should be
explored. This can be achieved if we can easily identify: (a) people in pre-
clinical stage of OA, (b) people at extreme high risk, and (c) determinants
for a deterioration into a clinically manifest OA.
Therefore, the present study has two major aims: (1) to identify early
predictive signs of clinically manifest OA of the knee in predeﬁned high-
risk groups, and (2) to identify extremely high-risk groups to develop knee
OA, by establishing what additional factors determine a clinically manifest
OA in a pre-deﬁned high-risk group.
Methods: A nested prospective cohort of 800 women aged 45−60 years
will be studied. These women were part of the participants who were
invited from 2006 onwards to extend the Rotterdam Study. We included
the following high-risk groups: middle-aged females without OA, but
with known risk factors for knee OA like overweight (400 women),
malalignment (100 women), and history of knee trauma (100 women).
Furthermore, we include a group with unilateral knee OA (100 women),
and 100 female controls (without OA and risk factors).
At baseline all participants of the Rotterdam Study had x-rays and whole-
body dexa scans, blood and urine was collected and a questionnaire was
administered.
Participants are identiﬁed based on data from baseline measurement
of the Rotterdam study and their knee x-rays, which are scored for OA
with Kellgren and Lawrence classiﬁcation system. After identiﬁcation of
women at high risk a telephonic screening for pain and contraindications
for MRI is done. If eligible, they are asked to visit the research centre for
an additional questionnaire and a MRI scan and physical examination of
both knees. MRI will be scored for OA with Knee Osteoarthritis Scoring
System (KOSS), and shape modelling based on x-rays will be done as
well as quantitative scoring of cartilage on MRI. Physical examination
contains the SQUASH and KOOS among other things. Every 1.5 year a
questionnaire will be send to the participants and ﬁrst follow-up will be
after 3 years, with in principal unlimited follow up every 3 years.
Results: We started in august 2007, and included 344 women so far, of
which 205 in the overweight group, 98 in the group with malalignment,
25 in the group with unilateral knee OA, 15 in the history of trauma group
and invited 46 controls. The only high-risk group in which women can
have pain is the high-risk group with unilateral knee OA. We aim to fulﬁll
the inclusion in April 2009.
Conclusions: Our cohort is more or less comparable with the Incidence
subcohort of the Osteoarthritis Initiative (OAI). A difference is that all
our participants in high-risk groups will not have knee pain, except the
unilateral knee OA group. All participants in the Incidence subcohort of
OAI in age category of 45−49 will have knee pain and all in age-category
50−69 can have knee pain. Furthermore, we have another risk group
with malalignment in our study. Therefore, our study can give important
information in addition to the OAI Incidence subcohort as well as essential
replication data.
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Purpose: The cause of primary osteoarthritis/osteoarthrosis (OA) has a
mechanical background. Excessive joint loading is suspected to initiate
a sequence of events that may eventually lead to joint degradation. One
of these events is the thickening and stiffening of the subchondral bone
(SCB). SCB and the overlying articular cartilage perform as a functional
unit. Presently, little is known about the mechanical interaction between
cartilage and bone in the etiology of OA.
OA is one of the most common arthritis forms affecting the temporo-
mandibular joint (TMJ). Micro-computed tomography (mCT) can be used
to detect OA-related bone abnormalities like erosion and osteophytosis
of the TMJ components (i.e., condyle, fossa, and tubercle) and to assess
the complete bone structure. The articular cartilage covering the condyle,
fossa and tubercle, as well as the cartilaginous articular disc, may also be
affected by OA-associated degenerative changes. It is difﬁcult to visualize
these structures directly with mCT. However, assessment of cartilage can
be facilitated by applying a hydrophilic contrast agent. The aim of this
study was to test the application of a highly hydrophilic, tri-iodinated
contrast medium (Optiray) for in vitro assessment of bone and cartilage
components with mCT in the human TMJ.
Methods: Three human TMJ samples (1 healthy, 2 OA-classiﬁed) were
treated with contrast medium Optiray (Tyco Healthcare Nederland BV,
the Netherlands) to enhance cartilage contrast. The samples were sub-
merged for two hours in Optiray (51% ioversol). Before and after this
treatment, the samples were scanned and evaluated with a mCT system
(mCT 40, Scanco medical AG, Switzerland, resolution: 18 mm). During
scanning, the samples were submerged in a hydrophobic ﬂuid to prevent
diffusion of Optiray out of the soft tissues. From the images, the thickness
of the cartilage layers was determined in three regions (i.e., medial,
midsagittal, and lateral). Furthermore, the images were segmented and
3D reconstructions could be made to visualize bone and cartilage tissue
separately.
Figure 1 (a) Midsagittal cross-section of a healthy TMJ after Optiray
treatment. (b) Enlargement of articular cartilage (AC). (c) Superior view
of OA-classiﬁed condyle and (d) overlying articular cartilage.
